Synthetic long peptide vaccine (Leiden University Medical Center)

N/A

Report date: 2022/03/17 14:08:32

Base Information

Drug NameSynthetic long peptide vaccine (Leiden University Medical Center)
Drug Alias NameSLP vaccine (cervical cancer)HPV16 E6/E7 SLP vaccine (cervical cancer)
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A